Skip to main content
Clinical Trials/NL-OMON56667
NL-OMON56667
Not yet recruiting
Not Applicable

FeAsibility of a PReoperative, multimodal lifestyle InterventiOn in patients with breast cancer ReceivIng neoadjuvant chemotherapy (APRIORI-study) - APRIORI-study

Medisch Universitair Ziekenhuis Maastricht0 sites11 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Medisch Universitair Ziekenhuis Maastricht
Enrollment
11
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Medisch Universitair Ziekenhuis Maastricht

Eligibility Criteria

Inclusion Criteria

  • Patients diagnosed with stage I\-III breast cancer eligible for neoadjuvant
  • intravenous chemotherapy at the Maastricht University Medical Center
  • Aged \>\=18 years
  • Eastern Cooperative Oncology Group (ECOG) Performance Status Scale
  • grade 0\-1 (Table 1\) \[40,41]
  • Enough understanding of the Dutch language

Exclusion Criteria

  • Human Epidermal growth factor Receptor 2 (HER2\) \- positive tumour
  • Scalp cooling
  • Recurrent breast cancer
  • Conditions that seriously hamper physical exercise
  • Incapacitated subjects as reported by the attending medical specialist in the
  • medical record. When any doubt arises, the patient will not be considered

Outcomes

Primary Outcomes

Not specified

Similar Trials